Company Info

Company Info

RATIO ANALYSIS

Parmax Pharma Ltd.

You can view the ratio analysis for the last 5 years.
GO

BSE

Nov 18, 04:01
33.80 +1.72 (+ 5.36%)
Volume 209
Prev. Close 32.08
Open Price 32.08
Today's Low / High
32.08
     
33.80
Bid Price(Qty.) 0.00 (0)
Open Pr.(Qty.) 0.00 (0)
52 Wk Low / High
29.30
     
55.02
Parmax Pharma Ltd.is not traded in NSE
ISIN No INE240T01014 Market Cap. ( in Cr. ) 12.65 P/BV -4.69 Book Value ( ) -7.21
BSE Code 540359 52 Week High/Low ( ) 55/29 FV/ML 10/1 P/E(X) 0.00
NSE Code - Book Closure 30/09/2024 EPS ( ) 0.00 Div Yield (%) 0.00
ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue10.0010.0010.0010.0010.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)-5.60-11.33-0.280.382.02
Diluted EPS (Rs.)-5.60-11.33-0.280.382.02
Cash EPS (Rs.)-2.39-9.143.994.666.06
Book Value[Excl.RevalReserv]/Share (Rs.)-4.470.1513.1513.3813.07
Book Value[Incl.RevalReserv]/Share (Rs.)-4.470.1513.1513.3813.07
Revenue From Operations / Share (Rs.)63.3624.8334.6541.0058.87
PBDIT / Share (Rs.)0.66-7.465.155.897.87
PBIT / Share (Rs.)-1.66-11.310.931.553.51
PBT / Share (Rs.)-5.38-12.710.100.682.71
Net Profit / Share (Rs.)-4.70-12.98-0.230.311.69
      
PROFITABILITY RATIOS     
      
PBDIT Margin (%)1.04-30.0514.8714.3613.37
PBIT Margin (%)-2.61-45.542.693.775.96
PBT Margin (%)-8.49-51.170.291.664.61
Net Profit Margin (%)-7.42-52.28-0.670.772.87
Return on Networth / Equity (%)0.00-8146.36-1.772.3712.96
Return on Capital Employeed (%)-12.90-82.273.966.4613.60
Return On Assets (%)-11.16-37.69-0.590.783.31
Long Term Debt / Equity (X)-3.8783.260.760.750.93
Total Debt / Equity (X)-3.8783.260.760.750.93
Asset Turnover Ratio (%)1.660.670.860.891.20
      
LIQUIDITY RATIOS     
      
Current Ratio (X)0.760.621.050.890.91
Quick Ratio (X)0.510.360.450.500.56
Inventory Turnover Ratio (X)7.542.101.541.974.02
      
COVERAGE RATIOS     
      
Interest Coverage Ratio (%)0.50-5.346.226.799.89
Interest Coverage Ratio (Post Tax) (%)-0.74-8.300.711.373.13
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)23.4218.5317.5921.6518.69
EV / Net Operating Revenue (X)0.931.681.141.190.71
EV / EBITDA (X)89.79-5.587.678.265.33
MarketCap / Net Operating Revenue (X)0.661.150.870.990.60
Price / BV (X)-9.46179.122.313.052.72
Price / Net Operating Revenue (X)0.661.150.870.990.60
EarningsYield-0.11-0.45-0.010.010.04